QSS
LXRX icon

Quantitative Systematic Strategies’s Lexicon Pharmaceuticals LXRX Stock Holding History

Quantitative Systematic Strategies’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-34,086
Closed -$117K – 707
2020
Q4 		$117K Buy
+34,086
New +$65K 0.02% 583
2019
Q3 		– Sell
-20,648
Closed -$130K – 543
2019
Q2 		$130K Buy
20,648
+8,302
+67% +$49.7K 0.02% 433
2019
Q1 		$69K Sell
12,346
-36,550
-75% -$222K 0.02% 359
2018
Q4 		$325K Buy
48,896
+26,543
+119% +$215K 0.07% 385
2018
Q3 		$239K Buy
22,353
+532
+2% +$6.1K 0.05% 476
2018
Q2 		$262K Buy
21,821
+2,650
+14% +$27.1K 0.05% 500
2018
Q1 		$164K Buy
19,171
+7,296
+61% +$67.5K 0.03% 581
2017
Q4 		$117K Buy
+11,875
New +$123K 0.03% 518

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantitative Systematic Strategies's LXRX Position: Q1 2021 in Review

Quantitative Systematic Strategies sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2021, closing a stake of 34,086 shares — an estimated $117K sold.

Quantitative Systematic Strategies first reported a position in LXRX in Q4 2017 and held it in 8 quarters. The position peaked at $325K in Q4 2018. 107 funds tracked by Wall St. Rank hold LXRX as of Q1 2021.

  • Quantitative Systematic Strategies reported no remaining Lexicon Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 34,086 Lexicon Pharmaceuticals shares in Q1 2021, an estimated $117K.
  • Quantitative Systematic Strategies first reported a position in Lexicon Pharmaceuticals in Q4 2017 and held it in 8 quarters.
  • Quantitative Systematic Strategies's Lexicon Pharmaceuticals position peaked at $325K in Q4 2018.
  • 107 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2021, filed 6 May 2021.